While STING activation in antigen-presenting cells (APCs) plays an important role in the anti-cancer effects of STING agonists38, STING activation by cGAMP in TRAMP-C2 cells was critical for CD8+ T-cell infiltration into the tumor microenvironment. This evidence concerns the gene CD8A and cancer.